Ing Investment Management »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Ing Investment Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $206M 176M 1.17
2024-06-30 $175M 162M 1.08
2024-03-31 $120M 127M 0.94

More positions owned by Ing Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Servicenow (NOW)
JPMorgan Chase & Co. (JPM)
Wells Fargo Perp Pfd Cnv A (WFC.PL)
Palo Alto Networks (PANW)
Datadog Cl A Com (DDOG)

View all positions for Ing Investment Management

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Deerfield Management Company
Aequim Alternative Investments
Lazard Asset Management
BlackRock
Davidson Kempner Capital Management
Calamos Advisors
Invesco
BlackRock
State Street Corporation
Morgan Stanley
MacKay Shields
Shenkman Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1